PER 4.94% 8.5¢ percheron therapeutics limited

Givinostat also has been tested in adults with Becker muscular...

  1. 4,317 Posts.
    lightbulb Created with Sketch. 2019
    Givinostat also has been tested in adults with Becker muscular dystrophy. Top-line results from a Phase 2 trial (NCT03238235) showed that treatment failed to reduce muscle scarring, a main trial goal, but its use stopped further muscle shrinkage and fat infiltration, suggesting it may slow or prevent disease progression.

    I wasnt correct in what I said about the adult trial.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.5¢
Change
0.004(4.94%)
Mkt cap ! $76.63M
Open High Low Value Volume
8.1¢ 8.5¢ 8.1¢ $26.33K 318.5K

Buyers (Bids)

No. Vol. Price($)
4 135273 8.3¢
 

Sellers (Offers)

Price($) Vol. No.
8.5¢ 137050 3
View Market Depth
Last trade - 13.50pm 28/06/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.